SCHEMBL4923910

SCHEMBL4923910

COc1ccccc1Nc1nc(C)c(C(=O)N2CCc3ccccc3C2)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.58
MAPT P10636 9/20 0.57
ALDH1A1 P00352 7/20 0.57
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
L3MBTL1 Q9Y468 3/20 0.51
MDM2 Q00987 1/20 0.51
TRPC3 Q13507 1/20 0.51
TRPC6 Q9Y210 1/20 0.51
POLB P06746 5/20 0.50
HTT P42858 4/20 0.50
GAA P10253 4/20 0.50
LMNA P02545 2/20 0.50
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47
PDGFRB P09619 1/20 0.47
KDR P35968 1/20 0.47
HPGD P15428 5/20 0.46
NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924592 0.93 MAPT (0.62) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4923733 0.81 MAPT (0.52) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4919203 0.80 TRPC3 (0.55) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4926963 0.80 KMT2A (0.56) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4927878 0.78 MAPT (0.54) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4919897 0.77 CYP2C9 (0.57) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4924626 0.77 MAPT (0.76) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4925449 0.76 MAPT (0.56) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL4924614 0.76 HSD17B10 (0.60) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL14184710 0.75 MEN1 (0.57) KDM4EMAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 KDM4E 1589/4885MAPT 1729/4885ALDH1A1 1395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.